BioSpace News Archive

Celcuity Inc. today announced its participation in the 22nd Annual Needham Virtual Healthcare Conference.

PerkinElmer Inc. (NYSE: PKI), today announced that it will release its first quarter 2023 financial results prior to market open on Thursday, May 11, 2023.

Agilent Technologies Inc. (NYSE: A) today announced a strategic partnership with PathAI, a leading provider of AI-powered research tools and services for pathology, to deliver biopharmaceutical organizations a solution that combines Agilent’s assay development expertise and PathAI’s algorithm development capabilities.

Synthekine Inc ., an engineered cytokine therapeutics company, today announced that two poster presentations showcasing its next series of oncology programs will be delivered at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023 taking place in Orlando, FL from April 14-19, 2023.

Visus Therapeutics Inc. today announced Jehan Tamboowalla joined the company as senior vice president of business development and marketing.

Panbela Therapeutics, Inc today announced the first patient enrolled in a Phase II double-blind, randomized study to evaluate CPP-1X-T (Eflornithine tablets) for recent onset type 1 diabetes.

MAIA Biotechnology, Inc. (NYSE American: MAIA ) today announced that it will present a poster that will feature the design of its ongoing Phase 2 clinical trial, THIO-101 evaluating THIO in patients with advanced Non-Small Cell Lung Cancer (NSCLC).

Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor DNA (AIR-DNA) TCR and BCR kits which provide rapid, single-tube PCR-based assays to analyze the genomic diversity of receptors from T-cells or B-cells from a wide range of sample types, including whole blood, tissue biopsies, FFPE and more.

AIM ImmunoTech Inc. today announced the appointment of W. Neal Burnette, Ph.D., as Chairman of its Scientific Advisory Board (“SAB”).

Gilead Sciences: Originally published by Gilead Sciences. Dr. Jeffrey Lazarus was studying at New York University in the late 1980s when he saw first-hand the devastation of the HIV epidemic.